Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bryan Springer

Orthopaedic Surgery Jacksonville, FL Medical Doctor

NPI 1932182086 CMS profile 177892

4500 San Pablo Rd S, Jacksonville, FL 32224

Open in the dashboard

General payments

$6,296,237

500 records reported · program years 2019–2025

Research payments

$1,000

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$31,421 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Bryan Springer of Jacksonville, FL is reported in the CMS Open Payments database as having received $6,296,237 across 500 general payments and $1,000 in research payments paid to them. Separately, studies naming them as principal investigator received $31,421 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $832,958 87
2025 Research $1,000 2
2024 General $1,128,101 91
2023 General $1,091,122 81
2022 General $967,688 61
2021 General $907,052 46
2020 General $750,660 27
2019 General $618,655 107

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bryan Springer
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Bryan Springer were reported at $832,958. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Bryan Springer Orthopaedic Surgery median Middle half National median
2019 $618,655 $644 $140–$2,844 $163
2020 $750,660 $312 $75–$1,860 $114
2021 $907,052 $520 $117–$2,495 $132
2022 $967,688 $598 $128–$2,731 $149
2023 $1,091,122 $461 $128–$2,264 $160
2024 $1,128,101 $497 $134–$2,475 $164
2025 $832,958 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $5,804,596 392 payments
  2. Osteoremedies, LLC $422,365 65 payments
  3. ConvaTec Inc. $49,775 21 payments
  4. Signature Orthopaedics USA Corp $9,000 1 payment
  5. Ethicon US, LLC $7,313 3 payments
  6. OMNIlife science, Inc $1,000 2 payments
  7. Ethicon Inc. $585 1 payment
  8. Orpyx Medical Technologies Inc. $400 1 payment
  9. Zimmer Biomet Holdings, Inc. $252 4 payments
  10. Heron Therapeutics, Inc. $180 2 payments
  11. Other $771 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $5,998,984 59 payments
  2. Consulting Fee $212,133 99 payments
  3. Travel and Lodging $75,157 196 payments
  4. Food and Beverage $9,963 146 payments
Products named General payments · program years 2019–2025
  1. ACCOLADE Hips $4,398,745 24 payments
  2. ACCOLADE Hips $1,214,771 15 payments
  3. TRIDENT $1,068,696 8 payments
  4. TRIATHLON $355,301 29 payments
  5. REMEDY SPACER Orthopedic $80,999 4 payments
  6. REMEDY SPACER Orthopedic $80,999 4 payments
  7. REMEDY SPACER Orthopedic $80,999 4 payments
  8. REMEDY SPACER Orthopedic $80,999 4 payments
  9. Remedy Spectrum GV Spacer $78,641 4 payments
  10. MAKO $74,511 192 payments
  11. Other $481,249 222 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Stryker Corporation $1,000 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

103

Median for Orthopedic Surgery: 203

Drug cost

$515

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 18 $144
Oxycodone Hcl Generic 21 $109
Tramadol Hcl Generic 20 $92
Diclofenac Sodium Generic 11 $85
Meloxicam Generic 15 $53
Amoxicillin Generic 18 $32

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$169,384

Of which drugs: $912

Medicare patients

276

Average age 74

Services billed

624

150 women, 126 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 29%
Chronic kidney disease 27%
Diabetes 25%
Cancer 20%
Depression 19%
Osteoporosis 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

502 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record